Manish Zinzuvadia, M.D.
NPI 1063726966ActiveIndividual· Psychiatry & Neurology, Psychiatry· New York, NY
Opted out of Medicare from October 2024 to October 2028. Psychiatry & Neurology, Psychiatry (M.D.) in New York, New York, licensed in NY, with an NPI issued in August 2010. Part D covered 7,381 prescriptions written in 2024, 84% of them generic. E.R. Squibb & Sons, L.L.C. was the largest of 10 companies reporting payments in 2025, $315,783 in all, mostly speaking and faculty fees.
Overview
| NPI | 1063726966 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Aug 3, 2010 |
| Last updated in NPPES | Mar 7, 2016 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Psychiatry & Neurology, Psychiatry Primary | 2084P0800X | 267628 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Oct 1, 2024 – Oct 1, 2028 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 7,381 · 7,572 30-day fills |
|---|---|
| Patients | 291 |
| Total drug cost | $3,650,016 |
| Generic share | 84% of claims |
Industry payments (Open Payments)
- 2025$315,783 · 351 payments from 10 companies
- 2024$238,981 · 312 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $111,826 | 106 |
| Teva Pharmaceuticals USA, Inc. | $60,212 | 53 |
| Otsuka America Pharmaceutical, Inc. | $56,171 | 44 |
| Alkermes, Inc. | $45,998 | 73 |
| Axsome Therapeutics, Inc. | $17,134 | 24 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$226,872 · 85 payments
- Honoraria$27,225 · 8 payments
- Travel and Lodging$26,895 · 69 payments
- Consulting Fee$23,449 · 10 payments
- Food and Beverage$11,240 · 178 payments
- Education$101.49 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Psychiatry & Neurology, Psychiatry providers in New York
- 1700700564
- 1336949171
- 1932730611
- 1063344588
- 1154734630
- 1326312059
- 1407175904
- 1497013478
- 1578153722
- 1952670572
- 1417877333
- 1528791258
All Psychiatry & Neurology, Psychiatry providers in New York →